4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-23-101237
Options or other derivatives
- Director acquired 85,715 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Forster Eliot Director | 2023-09-14 | Grant or award · Stock Options (Right to Buy) | +85,715 | 85,715 | D | ||
Loading xslF345X05/tm2326155d2_4.xml…